Akeso, Inc. (HKG:9926)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Therapies	2.30B
Therapies Growth	-53.96%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China	2.04B
China Growth	15.64%
United States	264.16M
United States Growth	-91.85%
Other Regions	2.45M
Other Regions Growth	84.01%